Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

New VIRCELL AMPLIRUN® SARS-CoV-2 B.1.1.7 RNA CONTROL

Products are for professional/laboratory use only.  We are pleased to announce the launch of the new Vircell AmpliRun® that contains the purified RNA of SARS-CoV-2 B.1.1.7 lineage, also known as VOC 202012/01 or UK variant, to be used as a control in nucleic acid amplification-based techniques.

AMPLIRUN® SARS-CoV-2 B.1.1.7 RNA CONTROL (Product code: VCMBC138-R)

Main Features:

  • First complete genome RNA control for SARS-CoV-2 B.1.1.7 lineage. 
  • Any target can be amplified.
  • It allows validation of RTPCR assays for SARS-CoV-2 B.1.1.7 detection.
  • Precise concentration in copies/µl verified by Digital Droplet PCR (ddPCR).
  • RNA origin from cultivated Spanish clinical isolate- sequence available
  • Non-infectious material with inactivation certificate
  • Lyophilized presentation
  • Can be used across various molecular testing platforms
  • RUO labelled – For research use only.

Find out more about AmpliRun Total SARS CoV-2 Control

Download Flyer >

Find out more about AmpliRun Total SARS CoV-2 Control SWAB

Download Flyer >



Request a Quote

Request Quote

Recent Posts

Savyon – SeroFIA™ Chlamydia

The Gold Standard in Chlamydia Serodiagnostics with High Sensitivity and User-Friendly Design The SeroFIA™ Chlamydia product line by Savyon Diagnostics consists of specific Microimmunofluorescence assays (MIF)…

Read full article

Certest – Clostidium Difficile Rapid Test

Simplifying C. difficile Screening with Certest Rapid Tests Certest provides a diverse range of rapid tests designed for simple yet highly sensitive screening assays, enabling…

Read full article

Vircell – Aspergillus Galactomannan Ag VirClia® Monotest

Meet the Aspergillus Galactomannan Ag Virclia® Monotest The reliable result, just when you need it Rapid, on‑demand detection of invasive aspergillosis — no batching, no delays,…

Read full article